ADVANCED ENZYME TECHNOLOGIES
|
The Current P/S Ratio of ADVANCED ENZYME TECHNOLOGIES is 5.08.
Share Price | ₹284.9 | Apr 02,2025 |
Market Cap | ₹3,188.0 Cr | |
Sales-TTM | ₹627.5 Cr | TTM-Consolidated Results |
Price/Sales | 5.08x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ADVANCED ENZYME TECHNOLOGIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹3,188.0 Cr] as on Apr 02,2025
(/) Sales [ ₹627.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.08x ]
Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '5.08 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ADVANCED ENZYME TECHNOLOGIES !
The chart below summarizes the trend in P/S Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.
Historical PS (Price/Sales) ratio chart of ADVANCED ENZYME TECHNOLOGIES
PS Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.65x.
- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 5.96x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2021 at 7.68x.
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2020 of 3.6x.
How does ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ADVANCED ENZYME TECHNOLOGIES | 627.5 | 5.08 | 3,188.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.97 | 411,306.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.56 | 150,343.0 |
CIPLA LTD | 26,981.2 | 4.35 | 117,323.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.61 | 108,619.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.07 | 95,941.5 |
MANKIND PHARMA LTD | 11,641.0 | 8.58 | 99,891.5 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.03 | 89,680.6 |
LUPIN LTD | 22,001.6 | 4.17 | 91,742.2 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.18 | 67,294.6 |
ABBOTT INDIA LTD | 6,243.2 | 10.07 | 62,839.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.18x |
Max industry PS | 16.56x |
Median industry PS | 5.08x |
Average industry PS | 6.88x |
You may also like the below Video Courses